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Mast cells are multifunctional immune cells scattered in tissues near blood vessels
and mucosal surfaces where they mediate important reactions against parasites and
contribute to the pathogenesis of allergic reactions. Serine proteases released from
secretory granules upon mast cell activation contribute to these functions by modulating
cytokine activity, platelet activation and proteolytic neutralization of toxins. The forced
release of granule proteases into the cytosol of mast cells to induce cell suicide has
recently been proposed as a therapeutic approach to reduce mast cell numbers in
allergic diseases, but the molecular pathways involved in granule-mediated mast cell
suicide are incompletely defined. To identify intrinsic granule proteases that can cause
mast cell death, we used mice deficient in cytosolic serine protease inhibitors and
their respective target proteases. We found that deficiency in Serpinb1a, Serpinb6a,
and Serpinb9a or in their target proteases did not alter the kinetics of apoptosis
induced by growth factor deprivation in vitro or the number of peritoneal mast cells
in vivo. The serine protease cathepsin G induced marginal cell death upon mast cell
granule permeabilization only when its inhibitors Serpinb1a or Serpinb6a were deleted.
In contrast, the serine protease granzyme B was essential for driving apoptosis in mast
cells. On granule permeabilization, granzyme B was required for caspase-3 processing
and cell death. Moreover, cytosolic granzyme B inhibitor Serpinb9a prevented caspase-
3 processing and mast cell death in a granzyme B-dependent manner. Together,
our findings demonstrate that cytosolic serpins provide an inhibitory shield preventing
granule protease-induced mast cell apoptosis, and that the granzyme B-Serpinb9a-
caspase-3 axis is critical in mast cell survival and could be targeted in the context of
allergic diseases.
Keywords: serpins, lysosomal peptidases, cell death, granzyme B, lysosomal permeabilization, mast cells, serine
protease
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INTRODUCTION
Developing from bone marrow precursors, mature mast cells are
scattered in tissues and found strategically placed in the proximity
of blood vessels, nerves, hair follicles and mucosal surfaces. Since
their discovery by Paul Ehrlich 140 years ago, physiological and
pathological functions of mast cells have been debated (Maurer
et al., 2003; Bradding and Pejler, 2018). The textbook view is
that mast cells contribute prominently to IgE-mediated allergic
reactions and control parasite infections via the rapid release of
mast cell granule contents (Galli et al., 2008). Beyond essential
contributions to allergy and the control of helminth infection,
novel functions linked to degranulation of mast cells have
been demonstrated in innate and adaptive immune responses
against various microbes, neoplasia, and chronic non-allergic
inflammatory diseases (Galli et al., 2015; Oskeritzian, 2015).
Among the preformed factors released by degranulation of
mast cells, specialized proteases act to amplify or dampen
inflammation and, importantly, to inactivate endogenous and
exogenous toxins (Metz et al., 2006; Piliponsky et al., 2008,
2012; Akahoshi et al., 2011; Galli et al., 2015; Waern et al.,
2016). Among these granule proteases are chymases, which
are serine proteases that evolved by gene duplication from a
common ancestor shared with granzymes, cathepsin G (CatG)
and complement factor D. These protease genes are located on
three conserved loci in vertebrates (Ahmad et al., 2014). Mast
cell granules also store soluble α- and β-tryptases, which are
serine proteases that evolved from membrane-bound γ-tryptases
independently of chymases (Trivedi et al., 2007). Finally, mast cell
granules also contain other serine proteases such as granzyme B
(GzmB) and CatG, which are not restricted to mast cells. Thus,
mast cells store a range of serine proteases in their granules, and
these proteases may also induce proteolysis and cell suicide if
released from granules into the cytosol.
Protease inhibitors such as clade B serpins have a nuclear
and/or cytoplasmic intracellular localization and promote
survival of neutrophils, NK and activated cytotoxic T cells
(Kaiserman and Bird, 2010; Benarafa and Simon, 2017). The
specific function of intracellular serpins in mast cell homeostasis
has not been elucidated but expression analysis from the
literature and publicly available resources support the hypothesis
that intracellular serpins may provide a survival shield in mast
cells against their own granule proteases. Indeed, the cytosolic
inhibitor SERPINB6 is expressed in mast cells in the lung, skin
and tonsils, as well as in mastocytoma and systemic mastocytosis
(Strik et al., 2004). SERPINB6 forms inhibitory complexes with
monomeric β-tryptase (Strik et al., 2004) and is one of the best-
characterized inhibitors of CatG (Scott et al., 1999). In addition
to SERPINB6, mast cells express SERPINB1, a related cytosolic
serpin that inhibits CatG and chymase, as well as other leukocyte
granule proteases such as neutrophil elastase, proteinase-3, and
granzyme H (Cooley et al., 2001; Benarafa et al., 2002; Wang
et al., 2013). SERPINB9 inhibits GzmB and is expressed in natural
killer cells, cytotoxic T lymphocytes, dendritic cells as well as mast
cells (Bird et al., 1998; Hirst et al., 2003; Bladergroen et al., 2005).
Here, we used mice deficient in Serpinb1a (Sb1a−/−), Serpinb6a
(Sb6a−/−), Serpinb9a (Sb9a−/−), and their target proteases to
investigate serpin function in mast cell homeostasis and survival
upon granule permeabilization and growth factor deprivation
in vitro. We identify a cytoprotective function for these serpins
and a major function for GzmB in inducing mast cell apoptosis
following cell-intrinsic granule leakage.
RESULTS
Serine Proteases and Caspases Induce
Cell Death in Mouse and Human Mast
Cells
Permeabilization of granules with L-leucyl-L-leucine methyl ester
(LLME), a well-characterized lysosomotropic agent, induces cell
death in various leukocytes containing granules (Thiele and
Lipsky, 1986, 1990a,b). Melo et al. (2011a, 2015) reported that
mast cells are sensitive to LLME-induced death, but the precise
molecular mechanisms and whether proteases are involved
remain unclear. We replicated their findings showing that
treatment of mouse bone marrow-derived mast cells (BMDMCs)
with LLME rapidly induces cell death (Figure 1A). Inhibition of
serine proteases with Pefabloc [a.k.a. 4-benzenesulfonyl fluoride
hydrochloride (AEBSF)] inhibited cell death in a dose-dependent
manner with optimal concentrations between 10 and 40 µM,
although it was toxic at higher concentrations (Figure 1A).
Inhibition of caspases with Q-VD-OPh also reduced death
of BMDMCs treated with LLME, with or without Pefabloc,
suggesting multiple proteases operate in this cell death pathway
(Figure 1B). In addition, we observed a synergistic pro-survival
effect of the inhibitors of serine proteases and caspases in the
human mast cell line HMC-1.2 treated with LLME (Figure 1C).
Importantly, LLME induced a strong activation of caspase-
3, which was inhibited by both Q-VD-OPh and by Pefabloc
(Figures 1D,E), suggesting that granule serine proteases may
contribute to caspase-3 activation leading to apoptosis.
Expression of Proteases and
Corresponding Cytosolic Inhibitors in
Mouse Bone Marrow-Derived Mast Cells
To start identifying the protease(s) responsible for inducing cell
death, we then evaluated the expression of a broad range of serine
proteases in WT BMDMCs during in vitro differentiation with
recombinant mouse IL-3 for 4, 6, and 8 weeks. mRNA expression
levels in WT BMDMCs revealed relatively high expression of
the mast cell-restricted serine proteases chymases mMCP-2 and
mMCP-5, and the tryptase mMCP-6, whereas mMCP-4, -7, -
9, and -10 expression was weak or not detected (Figure 2A).
Furthermore, we found that serine proteases cathepsin G (CatG),
granzyme B (GzmB), and granzyme A (GzmA), which are not
restricted to mast cells, are expressed at levels similar to MCP-
2, independently of the maturation state of the BMDMCs.
Perforin expression, in contrast, was not detected. Expression of
the metalloprotease carboxypeptidease 3 (MC-CPA3) was also
detected (Figure 2A).
Since BMDMCs expressed appreciable mRNA levels of CatG,
GzmA, and GzmB, we investigated the expression of their
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FIGURE 1 | Serine protease- and caspase-dependent cell death in human and mouse mast cells. (A–C) Survival of mast cells treated with L-leucyl-L-leucine methyl
ester (LLME) in presence of indicated concentrations of serine protease inhibitor (Pefabloc) and pancaspase inhibitor (Q-VD-OPh). Cell viability was determined by
flow cytometry as shown in Supplementary Figure 3. Data are shown as mean ± SEM. (A) WT mouse BMDMCs (n = 3). (B) BMDMCs of WT mice (n = 10).
(C) Human mast cell line HMC1.2 (n = 7–9). (B,C) Data are shown as mean ± SEM and were analyzed by one-way ANOVA (****p < 0.0001; ***p < 0.001; *p < 0.05;
ns, not significant). (D,E) Western blot analysis of caspase-3 cleavage in WT BMDMCs treated with LLME and inhibitors. (D) cell lysates and (E) cell lysate and
supernatant combined are shown. Fifteen µg of protein was loaded in each lane.
respective cytosolic inhibitors in WT BMDMCs during in vitro
differentiation. We found that two CatG inhibitors Serpinb1a
(Benarafa et al., 2002) and Serpinb6a (Sun et al., 1997) had the
highest expression levels. In contrast, transcription of Serpinb1b,
which also inhibits CatG, was not detectable. Expression of
the inhibitors of GzmA and GzmB, Serpinb6b (Kaiserman
et al., 2014) and Serpinb9a (Sun et al., 1997), respectively,
were also strongly expressed in all preparations and time
points. Expression of Serpinb6c, which has no known target
protease identified to date, was lower and not consistently
detectable (Figure 2B). Previous studies reported that GzmA
protein is not expressed in mast cells (Pardo et al., 2007;
Ronnberg et al., 2014). Using a GzmA-specific antibody and
intracellular staining, we found specific staining of GzmA in
wild-type NK cells, but not peritoneal mast cells nor BMDMCs,
suggesting that GzmA is post-transcriptionally regulated in
mast cells (Supplementary Figures 1A, 2). Because Sb6a−/−
and Sb9a−/− mice express green fluorescent protein (GFP)
under the control of the respective endogenous serpin promoter,
expression of the GFP reporter was quantified in BMDMCs
by flow cytometry. In agreement with the transcription data,
higher GFP levels were reported in mast cells when driven
by endogenous Serpinb6a promoter then when driven by the
endogenous Serpinb9a promoter. Furthermore, Sb6a−/− and
double-deficient Sb1a.Sb6a−/− mast cells had similar levels
of GFP expression (Figure 2C), indicating that deletion of
Serpinb1a does not alter basal expression of Serpinb6a in
BMDMCs. Co-expression of granule serine proteases and their
respective cytosolic inhibitory serpins in BMDMCs suggest cell-
intrinsic regulatory mechanisms as shown for other leukocytes
(Kaiserman and Bird, 2010; Benarafa and Simon, 2017). We then
compared the relative frequency of peritoneal mast cells in mice
lacking Serpinb1a (Sb1a−/−), Serpinb6a (Sb6a−/−), Serpinb9a
(Sb9a−/−), or both Serpinb1a and Serpinb6a (Sb1a.Sb6a−/−)
and found no statistically significant differences compared to WT
mice (Figure 2D and Supplementary Figures 1A,B). Together,
these findings show that these cytosolic serpins are not required
for development and maturation of mast cells under steady
state conditions.
Sb9a−/− Bone Marrow-Derived Mast
Cells Are Highly Sensitive to Granule
Permeabilization Induced Cell Death
Treatment of WT BMDMCs with LLME rapidly induced cell
death (Figure 3A and Supplementary Figure 3). The effect
of LLME on WT BMDMCs was partly reduced by caspase
inhibition with Q-VD-OPh (Figure 3B). Sb9a−/− BMDMCs
treated with LLME for 2 and 4 h showed significantly reduced
survival compared to WT BMDMCs with and without Q-VD-
OPh (Figures 3A,B). In contrast, Sb1a−/−, Sb6a−/−, and
Sb1a.Sb6a−/− BMDMCs treated with LLME showed comparable
survival to WT BMDMCs in the absence of Q-VD-OPh.
Treatment with Q-VD-OPh was less efficient at improving
survival in Sb1a−/−, Sb6a−/−, and Sb1a.Sb6a−/− BMDMCs
treated with LLME compared to WT, suggesting that multiple
proteolytic pathways contribute to the fate of mast cells upon
granule permeabilization and that cytosolic serpins, particularly
Serpinb9a, are important for survival following leakage of granule
proteases into the cytosol.
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FIGURE 2 | Expression of serine proteases and clade B serpins in BMDMCs. (A) Relative mRNA expression of mouse mast cell proteases (mMCP), including
chymases (Mcpt), tryptases (Tpsab), cathepsin G (Ctsg), granzymes (Gzm), carboxypeptidase 3 (Cpa3); and expression of perforin (Prf1) in WT mouse BMDMCs at
indicated time of in vitro differentiation with IL-3. (B) Relative mRNA expression of mouse serpin homolog genes in WT mouse BMDMCs at indicated time of in vitro
differentiation with IL-3. Data are shown as mean relative expression (bars) with individual BMDMC preparation (dots) (n = 4–6). Data are shown as median with
range. (C) Representative flow cytometry histogram (left) and mean ± SD (right) of mean fluorescence intensity (MFI) of reporter GFP signal in BMDMCs of Sb6a−/−,
Sb1a.Sb6a−/−, and Sb9a−/− mice. (D) Percentage of mast cells (IgE+, FcεR1a+, c-Kit+) in peritoneal cavity of WT, Sb1a−/−, Sb6a−/−, Sb1a.Sb6a−/−, and
Sb9a−/− female and male mice. Data were analyzed by one-way ANOVA and showed no difference relative to WT mice; data are shown as median (red line) and for
individual mice (n = 5–11/sex/genotype).
Granzyme B Is the Main Inducer of
Apoptosis in Mast Cells Upon Granule
Leakage
We then investigated BMDMCs of mice deficient for the target
proteases of the three serpins. In particular, GzmB−/− BMDMCs
were highly resistant to LLME-induced cell death compared
to WT BMDMCs (Figure 3C). Moreover, GzmB.Sb9a−/−
BMDMCs had similar resistance to LLME treatment as
GzmB−/− BMDMCs, and notably demonstrated higher
survival than WT BMDMCs. Therefore, the susceptibility
of Sb9a−/− BMDMCs to granule protease-mediated suicide
is principally due to unleashed GzmB activity (Figure 3B).
In the presence of Q-VD-OPh, survival improved in WT
BMDMCs, reaching the levels of GzmB−/− and GzmB.Sb9a−/−
BMDMCs, suggesting activation of caspases downstream of
GzmB (Figure 3C). In contrast, CatG−/− BMDMCs had no
survival benefit compared to WT BMDMCs (Figure 3D). The
survival of CatG.Sb1a.Sb6a−/− BMDMCs was also similar to
WT BMDMCs. Taken together, we conclude that GzmB is the
principal mediator of apoptosis following granule leakage in
mast cells, and that CatG detectably contributes to cell death only
in the absence of its two inhibitory serpins.
Deletion of Cathepsin G, Granzyme B or
Their Inhibitors Does Not Alter Bone
Marrow-Derived Mast Cell Differentiation
and Apoptosis Induced by Growth Factor
Deprivation
Survival and differentiation of BMDMCs in vitro is dependent on
the supply of growth factors, such as IL-3, which sustain survival
in part by inhibiting the intrinsic pathway of apoptosis (Karlberg
et al., 2010b; Ottina et al., 2015). To test whether intracellular
serpins are also involved in this intrinsic apoptosis pathway, we
measured survival of BMDMCs for 96 h after IL-3 withdrawal.
Survival of WT BMDMCs was substantially enhanced by the
caspase inhibitor Q-VD-OPh (Figure 4). In paired experiments,
we observed no significant difference in survival of Sb1a−/−,
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FIGURE 3 | Kinetics of cell death induced by granule permeabilization of BMDMCs. BMDMCs were treated with 250 µM L-leucyl-L-leucine methyl ester (LLME) with
or without 50 µM Q-VD-OPh as indicated: (A) serpin-deficient BMDMCs, (B) serpin-deficient BMDMCs with Q-VD-OPh, (C) GzmB−/− and GzmB.Sb9a−/−
BMDMCs with or without Q-VD-OPh, (D) CatG−/− and CatG.Sb1a.Sb6a−/− BMDMCs with or without Q-VD-OPh. (A–D) Viability was measured by flow cytometry
using annexin V-APC and PI/7-AAD labeling as shown in Supplementary Figure 3. WT BMDMCs in each panel are from paired experiments with the
corresponding mutant BMDMCs. Data are shown as mean ± SEM and were analyzed by two-way ANOVA (**p < 0.01; ***p < 0.001; ****p < 0.0001) (n = 5–14).
Sb6a−/−, Sb9a−/−, and Sb1a.Sb6a−/− BMDMCs compared to
WT with or without caspase inhibition (Figure 4A). Similarly,
BMDMCs derived from mice lacking GzmB and CatG showed
no significant protection against cell death induced by IL-3
withdrawal in presence or absence of Q-VD-OPh (Figure 4B).
Finally, we tested the survival of BMDMCs lacking the serpins
as well as their respective target protease. GzmB.Sb9a−/− and
CatG.Sb1a.Sb6a−/− BMDMCs were comparable in their survival
as paired cultures of WT BMDMCs (Figure 4C). These findings
indicate that although IL-3 removal triggers caspase activation
and apoptosis, this pathway does not require granule proteases
GzmB and CatG, and it is not regulated by cytosolic serpins.
Granzyme B Triggers the Activation of
Caspase-3 Following Granule Leakage
GzmB is a known inducer of apoptosis when delivered with
perforin to target cells by cytotoxic T lymphocytes and natural
killer cells. In the cytosol, GzmB processes multiple targets
including direct proteolytic activation of procaspase-3 and
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FIGURE 4 | Kinetics of apoptosis of BMDMCs after growth factor deprivation. BMDMCs differentiated in vitro for 6–9 weeks were cultured for 96 h in the absence of
recombinant IL-3 with (black line) or without (dashed line) of 50 µM Q-VD-OPh. Viability was assessed daily by flow cytometry using annexin V-APC/PI/7-AAD
exclusion: (A) serpin-deficient BMDMCs, (B) GzmB−/− and CatG−/− BMDMCs, (C) GzmB.Sb9a−/− and CatG.Sb1a.Sb6a−/− BMDMCs. WT BMDMCs in each
panel are from paired experiments with the corresponding mutant BMDMCs. Data are shown as mean ± SEM and were analyzed by two-way ANOVA (n = 5–15).
indirect activation via mitochondrial apoptotic events (Lord et al.,
2003). As caspase inhibition in GzmB−/− BMDMCs treated
with LLME only marginally improved survival (Figure 3B),
we tested whether GzmB is required for caspase activation
upon permeabilization of granules. Western blot analysis of
LLME-treated BMDMCs revealed that the active caspase-3 p17
fragment is generated in a dose-dependent manner in WT
and Sb9a−/− BMDMCs. Most importantly, absence of GzmB
in GzmB−/− and in GzmB.Sb9a−/− BMDMCs prevented the
cleavage of pro-caspase-3 p35 into p19 and the active p17
fragment. Conversely, caspase-3 processing was accelerated in
Sb9a−/− BMDMCs showing a complete conversion into the
active p17 fragment even treated at a low LLME concentration
(Figures 5A,B). Overall, our findings indicate that GzmB is
the most effective serine protease inducing apoptosis in mast
cells after leakage from granules. Sb9a acts as a gatekeeper for
caspase-3 activation by inhibiting GzmB. The higher survival
of GzmB−/− compared to WT BMDMCs (Figure 3C) suggest
that the protease eventually overwhelms its inhibitor to induce
caspase-dependent and caspase-independent cell death.
DISCUSSION
Mast cells contribute to severe symptoms associated with allergic
disorders (Galli et al., 2008). Reducing mast cell numbers
at disease-specific locations may therefore provide a novel
therapeutic axis (Karra et al., 2009; Hagforsen et al., 2015; Cildir
et al., 2017). Studies by Melo et al. (2011a,b) and Paivandy
et al. (2014) showed that mast cells are sensitive to death in
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 November 2021 | Volume 9 | Article 630166
fcell-09-630166 November 2, 2021 Time: 14:0 # 7
Burgener et al. Serpinb9 Promotes Mast Cell Survival
FIGURE 5 | GzmB-dependent cleavage of caspase-3 in LLME-treated BMDMCs. Western Blot analysis of caspase-3 cleavage in BMDMC of (A) WT, Sb9a−/− and
GzmB.Sb9a−/− mice (B) Sb9a−/− and GzmB−/− mice stimulated with 50 and 250 µM L-leucyl-L-leucine methyl ester (LLME) for 30 min.
response to lysosomotropic agents such as LLME and mefloquine
(an anti-malaria drug) due to cell-intrinsic leakage of their
secretory granules and that this form of cell death is mediated
by serine proteases and caspases. However, the serine protease(s)
involved in this cell death pathway remain incompletely defined:
BMDMCs deficient in the tryptase mMCP-6 were only marginally
protected against cell death and deletion of the chymase mMCP-
4 or the carboxypeptidase A (CPA) had no effect (Melo et al.,
2011b). Here we have confirmed that cell death induced by
LMME in human HMC-1.2 and mouse BMDMCs is efficiently
blocked by the combined use of inhibitors of caspases and
serine proteases.
We found that the serine proteases GzmB and CatG,
previously associated with granule-mediated suicide in other
leukocyte classes (Kaiserman and Bird, 2010; Benarafa and
Simon, 2017), are also present at appreciable levels in mast cells,
comparable to levels of the signature mast cell protease, chymase.
We hypothesized that these proteases may be involved in LLME-
mediated mast cell death, and that their cognate cytosolic serpins
might act to block this death pathway. Indeed, Sb1a −/−,
Sb6a−/− and, most severely, double-deficient Sb1a.Sb6a−/−
neutrophils have increased susceptibility to this form of cell death
as both serpins contribute additively to inhibit CatG (Burgener
et al., 2016, 2019). Moreover, granule permeabilization induces
cell death in LLME-treated neutrophils in a CatG-dependent
manner (Baumann et al., 2013; Burgener et al., 2019). Here,
we found that Serpinb1a, Serpinb6a (and their target CatG) are
highly expressed in mast cells. Yet, Serpinb1a and Serpinb6a had
limited protective effects on mast cells following LLME exposure
and this protection was only noticeable when caspases were
inhibited. Sb1a.Sb6a−/− BMDMCs did not show increased death
compared to single knockout Sb1a−/− or Sb6a−/− BMDMCs.
CatG deletion rescued this mild phenotype in CatG.Sb1a.Sb6−/−
BMDMCs, demonstrating that CatG has a real but minor effect
on mast cell suicide.
Similarly, Serpinb9 protects activated cytotoxic T lymphocytes
and natural killer cells against cell intrinsic death induced by
GzmB stored in their granules (Hirst et al., 2003; Ida et al., 2003;
Bird et al., 2014; Mangan et al., 2017). GzmB and its inhibitor
Serpinb9a are expressed in BMDMCs as well as in human
mast cells and cell lines (Bladergroen et al., 2005; Pardo et al.,
2007; Strik et al., 2007). Importantly, we found that GzmB−/−
BMDMCs are resistant to mast cell death induced by LLME
and that their survival was significantly improved compared
to WT BMDMCs. Conversely, Serpinb9a deletion increased
death of BMDMCs. The cytoprotective function of Serpinb9a
is principally through inhibition of GzmB since GzmB.Sb9a−/−
BMDMCs were as resistant to LLME as GzmB−/− BMDMCs.
We found that Pefabloc (AEBSF) protects against LLME-induced
death in WT BMDMCs, yet Pefabloc inhibits most serine
proteases but not GzmB. This suggests that other Pefabloc-
sensitive mast cell proteases, such as mMCP-6, may contribute
in part in this pathway via inactivation of Serpinb9a; such a
hypothesis remains to be explored.
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Our findings suggest multiple pathways leading to death in
mast cells via the activity of granule serine proteases GzmB and,
to a lesser extent, CatG. The GzmB pathway appears to be the
most prominent as GzmB induces apoptosis even in the presence
of its endogenous inhibitor Serpinb9a, whereas CatG appears to
be well under control of the abundant basal levels of Serpinb1a
and Serpinb6a. The relative contribution of serine proteases thus
depends on their abundance, especially relative to the levels of
cytosolic serpins and to the expression of downstream targets that
will accelerate cellular demise.
Our data indicates that GzmB contributes to the direct or
indirect activation of caspase-3 upon granule permeabilization.
Yet, caspase inhibition was not sufficient to block cell death.
This may be due in part to the ability of GzmB to induce
apoptosis via multiple independent pathways (Chowdhury and
Lieberman, 2008; Martinvalet, 2015). It has been proposed
that pro-caspase-3 is also stored and activated in a granzyme
B-dependent manner in mast cell secretory granules (Garcia-
Faroldi et al., 2013; Zorn et al., 2013). While we cannot exclude
the possibility that granule caspase-3 contributes to mast cell
death, our data support the view that caspase-3 activation
classically occurs in the cytosol. Indeed, Serpinb9a has a nucleo-
cytosolic localization and is not found in granules (Bird et al.,
2001), while Sb9a−/− BMDMCs treated with LLME showed
increased cleavage of caspase-3 into p17 active fragment. The
composition of granule cargo is regulated at several levels: the
presence of signal peptide is found at the N-terminus of serine
and cysteine proteases but not caspases, which are found in the
cytosol. The storage of some serine proteases in different granules
is further regulated by serglycin. Serglycin is required for the
packaging of most mast cell proteases, including chymases and
carboxylpeptidase and to a lesser extent tryptases (Ronnberg
et al., 2012). GzmB also requires serglycin for localization in
granules (Sutton et al., 2016), while CatG does not (Niemann
et al., 2007). Interestingly, mast cells of Serglycin−/− mice are
protected against LLME-induced apoptotic cell death (Melo
et al., 2011b). Our findings on GzmB are thus in agreement
with previous work demonstrating that a serglycin-dependent
protease is responsible for apoptotic death in mast cells following
granule permeabilization (Melo et al., 2012).
Mast cells are long-lived in tissues and their survival depends
on pro-survival signals and the regulation of the mitochondrial
pathway of apoptosis by B-cell lymphoma-2 (Bcl-2) family
proteins (Karlberg et al., 2010b; Garrison et al., 2012). Growth
factors such as IL-3 and the c-kit ligand stem cell factor (SCF)
sustain the survival of mast cells through increased expression
of anti-apoptotic Bcl-2 family proteins such as MCL-1 and
A1 (Xiang et al., 2001; Reinhart et al., 2018). Conversely,
withdrawal of IL-3 or SCF triggers the mitochondrial pathway of
apoptosis by increasing the expression of the BH3 only proteins
Puma and Bim, respectively (Moller et al., 2005; Ekoff et al.,
2007). In support of this model, we found that deletion of
Serpinb1a, Serpinb6a and Serpinb9a or their target proteases
CatG and GzmB does not alter the cell death kinetics of apoptosis
mediated by IL-3 withdrawal. Similarly, Serglycin−/− BMDMCs
undergo apoptosis normally upon IL-3 withdrawal (Melo et al.,
2011b). Targeting mast cells in allergic disorders or in systemic
mastocytosis using BH3 mimetics holds promise (Aichberger
et al., 2009; Karlberg et al., 2010a; Reinhart et al., 2018). Our
findings suggest that induction of GzmB-mediated death in mast
cells would provide an additional independent mechanism to
target mast cells that could be used in synergy with BH3 mimetics.
In conclusion, we have shown that cytosolic clade B serpins
provide a key protective shield in mast cells and prevent the
onset of a very rapid apoptotic-like cell death associated with
granule serine protease activity. The balance between GzmB
and Serpinb9a is particularly important to maintain mast cell
survival and the targeted release of GzmB in mast cells and/or
downregulation of Serpinb9 may be an interesting therapeutic
avenue to target mast cells.
MATERIALS AND METHODS
Mice
All animal studies were approved by the Cantonal Veterinary
Office of Bern and conducted in accordance with the Swiss
federal legislation on animal welfare. Mice were kept in SPF
facilities, in individually ventilated cages, with 12/12 light/dark
cycle, autoclaved acidified water, autoclaved cages including food,
bedding and environmental enrichment. Age and gender of
mice is indicated for each in vivo or ex vivo model described
below as well as in figure legends. All gene targeted mice
were on the C57BL/6J background or had been backcrossed to
the C57BL/6J background for at least 10 generations. Sb1a−/−
(Serpinb1atm1.1Cben), Sb6a−/− (Serpinb6atm1.1Pib), Sb9a−/−
(Serpinb9atm1.1Pib) were described previously (Scarff et al.,
2003; Benarafa et al., 2007; Rizzitelli et al., 2012). CatG−/−
(Ctsgtm1Ley) and GzmB−/− (Gzmbtm1Ley) mice were kindly
provided by Christine Pham (Washington University, St. Louis,
MO) (MacIvor et al., 1999) and Australian Phenome Facility
(Heusel et al., 1994), respectively. Sb1a.Sb6a−/− mice were
generated by mating compound heterozygous F1 mice as
described previously (Burgener et al., 2019). All double and triple
knockout mice as GzmB.Sb9a−/− and CatG.Sb1a.Sb6a−/− mice
were generated in our facility by compound heterozygote mating.
Peritoneal Mast Cells and Flow
Cytometry
Peritoneal lavage was performed using 5 mL PBS supplemented
with 1% heat-inactivated FBS on healthy female and male
mice. Total cell numbers were evaluated by counting cells
manually in a Neubauer chamber. Relative percentages of
live mast cells were determined by flow cytometry; analysis
was performed using FlowJo with single cell gating, dead cell
exclusion using propidium iodide (PI) and, mast cells identified
as FcεRI+, IgE+, and, c-kit+. Single cell suspensions blocked
with anti-CD16/CD32 (clone 2.4G2) and stained for 30–40 min
on ice with fluorescently labeled antibodies (BioLegend, BD
Biosciences) were acquired using a 4-color FACS Calibur (BD
Biosciences). Mast cells were permeabilized using the Foxp3
buffer (eBioscience) and stained using an anti-mouse granzyme
A antibody (eBioscience, clone 3G8.5).
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Cell Culture
The human mast cell leukemia cell line HMC-1.2 was generated
as previously described (Dr. J. Butterfield) and kindly provided
by Prof. G. Nilsson (Karolinska Institute, Stockholm) (Butterfield
et al., 1988; Nilsson et al., 1994). HMC-1.2 cells were cultured
as previously described (Sundstrom et al., 2003). Bone marrow
derived mast cells (BMDMCs) were obtained by flushing
femurs and tibias bone marrow cells of 6–12 week old
female and male mice and cultured in DMEM with 2 mM
L-glutamine, supplemented with 10% heat-inactivated FBS, 50
µM β-mercaptoethanol, 1% penicillin/streptomycin, and 10
ng/mL recombinant mouse IL-3 (Peprotech). The cells were
maintained at a concentration of 2.5 × 105–1 × 106 cells/mL,
at 37◦C in 5–7% CO2. Maturity was assessed by analysis of
the expression of c-Kit, IgE, and FcεRI by flow cytometry 4–
5 weeks after isolation (Supplementary Figure 4). In various
assays, BMDMCs were seeded at 1 × 106 cells/mL and
incubated at indicated concentrations with L-leucyl-L-leucine
methyl ester (LLME) (Bachem, # G-2550), Q-VD-OPh (ApexBio,
#A1901) or Pefabloc SC (Sigma, #PEFBSC-RO). In some
experiments, mature BMDMCs (1.0 × 106/mL) were cultured
in absence of rmIL-3 with DMEM, 1% heat-inactivated FBS, 1%
penicillin/streptomycin up to 96 h with or without 50 µM Q-VD-
OPh (ApexBio, #A1901). Apoptosis and necrosis of mast cells
in vitro was determined by staining with Annexin V-fluorescein
isothiocyanate (FITC) or Annexin V-allophycocyanin (APC) and
propidium iodide (PI) or 7-aminoactinomycin D (7-AAD) at
RT for 15 min and measured with a 4-color flow cytometer
(FACScalibur, BD Biosciences).
Quantitative RT-PCR
RNA-isolation was performed using RNA-Bee (AMS
Biotechnology, #CS-501B). In brief, 3–5 × 106 BMDMCs
were resuspended in 1 mL RNA-Bee and total RNA extracted
following the manufacturers protocol. After DNAse treatment,
300 ng total RNA was reverse transcribed using ProtoScript III
reverse transcriptase and random primer mix (New England
Biolabs). Real-time quantitative PCR amplification was carried
out in duplicate or triplicate using Mastermix Plus SYBR Assay-
Low Rox (Eurogentec, #RT-SY2X-03+WOULRF) in a Vii7
thermocycler (Applied Biosystems). Sequences of the validated
specific primers for proteases, serpins and S16 ribosomal protein
(RPS16) are shown in Supplementary Table 1 (Chen et al., 2005;
Martin et al., 2005; Ekoff et al., 2007; Malbec et al., 2007; Andrew
et al., 2008; Cremona et al., 2013). For each sample, mRNA levels
were expressed relative to S16 expression.
Western Blot
BMDMCs were treated for 0.5 h with 50–500 µM L-leucyl-
L-leucine methyl ester (LLME) (Bachem, #G-2550) and lysed
in 0.1% Triton-X-100 lysis buffer without protease inhibitors
followed by 2× 30 s sonication (Soniprep 150 plus, MSE). Lysates
were centrifuged at 10,000 g for 10 min at 4◦C and supernatant
was collected. Total protein concentration in lysates were
determined by the BCA assay (Thermo Fisher Scientific, #23225).
Cell lysates were pooled with methanol/chloroform-precipitated
cell-free supernatants or cell lysates alone (30 µg total protein)
were resolved in SDS-PAGE under reducing conditions using
Tris-Glycine Buffer. After transfer on nitrocellulose, blocking
was performed using 5% skimmed milk and blots were
probed with rabbit anti-mouse caspase-3 (Cell Signaling, #9662)
and then stripped and reprobed with anti-β-Actin antibody
(Abcam, #ab8227).
Statistical Analysis
Statistical analysis was performed using Prism 8.0c (GraphPad,
San Diego, CA). Non-parametric tests were used to analyze data
from in vivo and ex vivo studies. Independent experiments were
performed and pooled, scatter plots represent individual mice
and horizontal lines indicate mean± SEM or median with range.
Experiments were analyzed by one-way or two-way ANOVA
with Tukey post-test and p-values of p < 0.05 were considered
statistically significant (∗∗∗∗P < 0.0001; ∗∗∗P < 0.001; ∗∗P < 0.01;
∗P < 0.05). Tests used and number of replicates are indicated in
figure legends.
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Supplementary Figure 1 | Analysis of peritoneal mast cells. (A) Flow cytometry
gating strategy of steady state peritoneal lavage cells to identify mast cells as
IgE+, FcεR1a+, and, c-Kit+. (B) Mast cells (IgE+, FcεR1a+, c-Kit+) in peritoneal
cavity of WT, serpin-deficient and protease-deficient mice. Data were analyzed by
one-way ANOVA and no difference was found for any deficient mouse relative to
WT mice; data are shown as median (red line) and for individual mice
(n = 3–11/sex/genotype).
Supplementary Figure 2 | BMDMCs and peritoneal mast cells do not express
granzyme A protein. (A) Representative flow cytometry plots of peritoneal mast
cells and identified as IgE+, FcεR1a+, and, c-Kit+. Data are representative of three
preparations of C57BL/6 wild-type mice at 6–12 weeks. (B) Representative flow
cytometry plots of BMDMCs cultured with IL-3 for 5 weeks. (C) Representative
flow cytometry plots of mouse spleen NK cells and CD8 T cells. Data are
representative of four C57BL/6 wild-type (WT) and five GzmA−/− mice at
6–12 weeks. (A–C) Expression of granzyme A was assessed in fixed and
permeabilized cells with a specific antibody.
Supplementary Figure 3 | Flow cytometry analysis of mast cells viability.
Representative flow cytometry dot plots and gating strategy for evaluating mast
cell survival with annexin V and propidium iodide staining. BMDMCs were treated
or not with LLME as indicated.
Supplementary Figure 4 | Maturity of BMDMCs after 4 weeks of in vitro
differentiation in presence of IL-3. (A) Flow cytometry gating strategy. (B)
Percentage of IgE+FcεR1a+c-Kit+ BMDMCs of each genotype after 4 weeks of
maturation in vitro with recombinant mouse IL-3.
Supplementary Figure 5 | Uncropped western blot of Figures 1, 5.
Representative uncropped western blots.
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